corticotherapie en 2012

EPU‐95'Montmorency'
!"#$%&'"()*+,'-%./)0"(&'(1/),1)2%.),34'5/)6)78#+$/(&)!*0)9::6:;<)
!""#$%!&%#'(!)%$!*+(,-+'"+%.'+)+'&(/#"&(0'%1+2"%&!%2+(,+(*!(23.%#'(,+()#'&)#2+'$4(
='>8/)5"-'%.)?)9)#1/)@/%()*"1.'()<A9B:)*"(&$"#/(-C)
=/-#+&%#'%&)?)9BD)#1/),/).%)!/#$/)<A)EB:)FG%(H'../)
IIIJKLM<A6$"(&$"#/(-CJ"#8)
(
(
CORTICOTHERAPIE'EN'2012'
$56789(:9;<=(:><?@>(<-A7:BC(=;(9D75C>(<=(,:E(F9A;G*=H("A:A=D(
"9:I?H9(<9()><9H?;9(%;89:;9(J(.K+)(L+A=M5;;9N(
,/$(<=(O(;5I96M:9(PQRP(
(
1. INTRODUCTION'
1.1. HISTORIQUE'
ROSS( T9C( 5MC9:IA8?5;C( A;A8565GHT?;?U=9C( <9( &V56AC( !<<?C5;( A88?:9;8( T-A889;8?5;( C=:( TA( 7A8V5T5@?9( <9C(
C=::>;AT9CEEE(
ROWQX( C=:( <9C( A:@=69;8C( 9D7>:?69;8A=D( Y:5Z;G">U=A:<( A[[?:69( U=9( \T9C( H5:8?H5C=::>;AT9C( C5;8(
9CC9;8?9TT9C(](TA(I?9EEE(
R^_^X( TA( <>C5D`H5:8?H5C8>:5;9( 9C8( <>H5=I9:89( 7A:( &E( 29?HVC89?;X( H9( U=?( A( 79:6?C( <-ACC=:9:( TA( C=:I?9( <9C(
A<<?C5;;?9;CE((
*A( 6?C9( ](TA(<?C75C?8?5;( <9C( HT?;?H?9;C( <9( TA( H5:8?C5;9( 9;( R^SQ( A( H5;C8?8=>( =;( 7:5@:BC(8V>:A79=8?U=9( 9;(
T-ACC5H?A;8(](TA( <>C5D`H5:8?H5C8>:5;9E($9C( ?675:8A;89C( <>H5=I9:89C( >8A?9;8( H5=:5;;>9C( 7A:( T-A88:?M=8?5;(
<=( /:?D('5M9T(<9(7V`C?5T5@?9( 98(<9(6><9H?;9(9;(R^SQ( ](<9=D(M?5HV?6?C89CX(+E$E(a9;<ATT(98(&E(29?HVC89?;(
75=:(T9=:C(8:AIA=D(C=:(T9C(V5:65;9C(H5:8?H5C=::>;AT9C(98(](=;(:V=6A85T5@=9(/EG"E(K9;Hb(75=:(T-=8?T?CA8?5;(
8V>:A79=8?U=9(<9(TA(H5:8?C5;9E((
1.2. LES'GRANDES'INDICATIONS'DE'LA'CORTICOTHERAPIE''
+TT9C(C5;8(7:>C9;8>9C(<A;C(T9(8AMT9A=(H?G<9CC5=CE(
(
(

P(
(
(
2. LA'MALADIE'DE'HORTON'
2.1. EN'BREF…'
*A(6ATA<?9(<9(K5:85;(L)KN(9C8(TA(7T=C([:>U=9;89(<9C(IACH=TA:?89C(C`C8>6?U=9CX(AI9H(=;9(7:><?T9H8?5;(75=:(
T9C(A:8B:9C(<9(TA:@9(98(<9(65`9;(HAT?M:9E((
"5;(?;H?<9;H9(7A:(79:C5;;9( c@>9(<9(7T=C(<9(SQ(A;C(IA:?9( C9T5;(T9C(:>@?5;C(d(<9(RSJ_SeRQQ(QQQE( %T(9D?C89(
=;9( A=@69;8A8?5;( <9( T-?;H?<9;H9( <9( TA( )K( 98( H9( 6AT@:>( T9C( H5::9H8?5;C( T?>9C( A=( I?9?TT?CC969;8( <9( TA(
757=TA8?5;E(+TT9(A889?;8(<9C(C=f98C(c@>C(<9(7T=C(<9(SQ(A;C(98(T9(:?CU=9(C9(6Af5:9(AI9H(T-c@9(7=?CU=-?T(9C8(PQ(
[5?C(7T=C(?675:8A;8(A7:BC(^Q(A;C(U=-9;8:9(SQ(98(WQ(A;CE(
2.2. LES'COMPLICATIONS'
*A( H567T?HA8?5;( 6Af9=:9( U=-9C8( T-A6A=:5C9( 5=( TA( H>H?8>( A( ;988969;8( :>@:9CC>( <97=?C( T-=8?T?CA8?5;( <9( TA(
H5:8?H58V>:A7?9( 9;( R^S_E( *A( [:>U=9;H9( <9( H98( >I>;969;8( IA:?9( <9( PQ( ]( WQ(g( 9;( [5;H8?5;( <9C( C>:?9C( 98(
C=:85=8(<=(65<9(<9(:9H:=8969;8(<9C(7A8?9;8CE(
*A(C=:65:8AT?8>(T?>9(TA()K(9C8(8:BC(IA:?AMT9(<9(hX_(](_SXS(g(C9T5;(T9C(C>:?9C(98(:9C89(H5;8:5I9:C>9X(HA:(9TT9(
;-A( 7=( i8:9( <>65;8:>9( H567A:A8?I969;8( ]( =;9( 757=TA8?5;( 8>65?;( A77A:?>9( 7A:( T-c@9E( %T( C-A@?8(
9CC9;8?9TT969;8(<-=;9(C=:65:8AT?8>(<-5:?@?;9(HA:<?5IACH=TA?:9E(*9C(<>HBC(C=:I?9;;9;8(A=(H5=:C(<9C(U=A8:9(
7:96?9:C( 65?C( <9( 8:A?8969;8X( 98( C5;8( <=C( ]( <9C( AHH?<9;8C( IACH=TA?:9C( H>:>M:A=D( 9;( HAC( <9( 6ATA<?9(
HT?;?U=969;8( 5=( M?5T5@?U=969;8( 6AT( H5;8:jT>9(k( 5=( ]( T5;@( 89:69( <=C( ]( <9C( A889?;89C( HA:<?AU=9C(
?CHV>6?U=9C(HV9l(T9C(7A8?9;8C(A`A;8(9=(<9([5:89C(<5C9C(<9(H5:8?H5m<9C(5=(=;9(6ATA<?9(6AT(H5;8:jT>9E(
*A( 65:M?<?8>( 9C8( >@AT969;8(T?>9( A=D( :?CU=9C(?;V>:9;8C(](TA( H5:8?H58V>:A7?9(A=(T5;@( H5=:C( L<?AMB89X( K&!X(
5C8>575:5C9([:AH8=:A?:9X(<>H5679;CA8?5;(HA:<?AU=9nN(U=?(A77A:A?CC9;8(<BC(TA(7:96?B:9(A;;>9X(HV9l(_S(](
WS(g(<9C(7A8?9;8CE(,A;C(7T=C?9=:C(>8=<9CX(TA(H5:8?H58V>:A7?9(](<5C9(>T9I>9(L7T=C(<9(RQ(6@ef(79;<A;8(7T=C(
<9(C?D(65?CN(9C8(ACC5H?>9(](=;(:?CU=9(AHH:=(<9(<>HBC(98(](=;9(65:M?<?8>(7T=C(?675:8A;89E((
2.3. LE'DIAGNOSTIC'
o(T-V9=:9(AH8=9TT9X(TA(M?57C?9( <-A:8B:9( 89675:AT9(:9C89(T9(69?TT9=:(65`9;(<9(75C9:(T9(<?A@;5C8?H(<9()KE(
)A?C( A=( H5=:C( <9C( <?D( <9:;?B:9C( A;;>9CX( T-=8?T?8>( <9( ;5=I9TT9C( 89HV;?U=9C( <-?6A@9:?9( 75=:( 75C9:( T9(
<?A@;5C8?H(<9(IACH=TA:?89(<9C(@:5C(IA?CC9A=D(A(>8>(>8=<?>9E(
2.4. LE'TRAITEMENT'DE'LA'MALADIE'DE'HORTON'
2.4.1. UNE'URGENCE,'MAIS'LA'MALADIE'DE'HORTON'EST'CURABLE'…'
*9( 8:A?8969;8( 9C8( MAC>( C=:( TA( H5:8?H58V>:A7?9( U=?( 79:698( =;9( A6>T?5:A8?5;( :A7?<9( <9C( C`678j69C( 6A?C(
<?6?;=9(A=CC?(T9(:?CU=9(<9(H567T?HA8?5;C(IACH=TA?:9C(](T5;@(89:69E((
*A(:A7?<?8>(<-?;C8A=:A8?5;(<=(8:A?8969;8(9;(HAC(<9(8:5=MT9C(I?C=9TC(9C8(T9(69?TT9=:([AH89=:(7:><?H8?[(<9(TA(
:>H=7>:A8?5;(HT?;?U=9E("?(TA(H5:8?H58V>:A7?9(9C8(?;C8A=:>9(9;(65?;C(<9(Ph(V9=:9CX(7T=C(<9(SQ(g(<9C(7A8?9;8C(
A=:5;8(=;9(A6>T?5:A8?5;(H5;8:9(W(g(A7:BC(Ph(V9=:9CE((
%T( ;-9D?C89( A=H=;( H5;C9;C=C( H5;H9:;A;8( T9( CHV>6A( 8V>:A79=8?U=9X( TA( <5C9( 98( TA( <=:>9( <9( 8:A?8969;8E(
.T5MAT969;8X(T-?;C8A=:A8?5;(:A7?<9(<9(TA(H5:8?H58V>:A7?9(9C8(:9H566A;<>9(7A:(85=CX(A[?;(<9(<?6?;=9:(T9C(
C?@;9C(HT?;?U=9C(98(<9(7:>I9;?:(T9C(H567T?HA8?5;C(?CHV>6?U=9CE((
2.4.2. LA'CORTICOTHERAPIE'RESTE'LE'TRAITEMENT'DE'REFERENCE'MAIS…'
%T(;-9D?C89(85=f5=:C(A=H=;(H5;C9;C=C(C=:(TA(<5C9(?;?8?AT9X(TA(<=:>9(<9(TA(H5:8?H58V>:A7?9(98(T9C(65<AT?8>C(<9(
<>H:5?CCA;H9( U=?( C5;8( 7T=8j8( MAC>9C(C=:( <9C(:9H566A;<A8?5;C( <-9D79:8CE( *A( 89;<A;H9( @>;>:AT9( 9C8( ](TA(
MA?CC9(<9C(<5C9C(98(](TA(:><=H8?5;(<9C(<=:>9C(<=([A?8(<9(TA(H565:M?<?8>(ACC5H?>(](H9(8:A?8969;8E(
*9C(7A8?9;8C(:>75;<9;8(@>;>:AT969;8(](<9C(<5C9C(IA:?A;8(9;8:9(QXS(98(QXp(6@eb@(7A:(f5=:E((

_(
(
&5=89C(T9C(69C=:9C(7:>I9;8?I9C(<=(8:A?8969;8(7A:(H5:8?H5m<9C(C5;8(?;C8A=:>9C(9;(6i69(8967CE((
o(7A:8?:(<9(p(5=(S(6@( <->U=?IAT9;8(7:><;?C5;9X( ?T(9C8(:9H566A;<>(<-Af5=89:(=;9(C=77T>69;8ACC?5;C(9;(
V`<:5H5:8?C5;9X(A?;C?(U=9(TA(:>AT?CA8?5;(<-=;(89C8(A=("`;AH8V>;9q(T-A::i8(<>[?;?8?[E((
+;( 65`9;;9X( p_(g( <9C( 7A8?9;8C( :9r5?I9;8( OXP(6@( ]( =;( A;( 98( _Q(g( C5;8( C9I:>C( 9;( RO( ]( Ph(65?CE( *A(
[:>U=9;H9(<9(TA(:9HV=89(IA:?9(<9(h(](pQ(g(9;([5;H8?5;(<9(TA(:A7?<?8>(<9(TA(<>H:5?CCA;H9E(
2.4.3. QUELLE'MOLECULE'?'
*9(HV5?D(<5?8(C9([A?:9(9;([5;H8?5;(<9C(HA:AH8>:?C8?U=9C(<9C(<?[[>:9;89C(65T>H=T9C(:>C=6>9C(<A;C(T9(8AMT9A=(
C=?IA;8E(%T(:975C9(C=:(=;(M5;(H567:56?C(9;8:9([:9?;A8?5;(98(9[[98(6?;>:AT5GH5:8?H5m<9E(
(
'
Molécules'
Équivalent'
Posologique'
mg'
Anti'
Inflamm.'
Rétention'
sodée'
Pouvoir'
Freinat.'
Naturels'
K`<:5H5:8?C5;9(
$5:8?C5;9(
PQ(6@(
PS(
R(
QEO(
R(
QEO(
R(
R(
D1'Dérivés'
/:9<;?C5T5;9(L"5T=7:9<sN(
/:><;?C5;9(L$5:8A;H`TsN(
S(
S(
_Gh(
_Gh(
QEO(
QEO(
R(
R(
Substitués'
Fluorés'9a'
&:?A6H?;5T5;9(
,9DA6>8VAC5;9(
Y98A6>8VAC5;9(
h(
QEpS(
QEpS(
SGRQ(
PQGhQ(
PSGhQ(
Q(
Q(
Q(
S(
SQ(
SQ(
Substitués'non'
Fluorés'
)98V`T7:9<;?C5T5;9(
L)><:5TsN(
$5:8?IAl5T(
h(
QE_(
hGS(
hQGSQ(
QEPGQES(
QEQS(
hGS(
SQ(
(
2.4.4. UNE'PRESCRIPTION'TYPE…'
%T([A=8(?;C?C89:(C=:(T-?;8>:i8(<-=;9(7:?C9(=;?U=9(T9(6A8?;(U=?(:><=?8(9[[98([:9?;A89=:(C=:(TA(C>H:>8?5;(<-!$&K(
U=?(IA(C9(C=79:75C9:(A=(7?H(7V`C?5T5@?U=9(<9(C>H:>8?5;(<9(H5:8?C5TE(%T(9C8(65;8:>(U=9(TA(7:?C9(9;(P([5?C(ef(
6Af5:9(T9C(9[[98C([:9?;A89=:CE(
(
Ordonnance'type'(traitement'pour'2'mois)'
(
G $5:8A;H`Ts(d(SQ(6@(9;(=;9(7:?C9(T9(6A8?;(LQEp(6@eb@efN(
G aA:<>@?Hs(d(RWQ(6@(R(CAHV98ef(
G ,?[[=(asd(P(@>T=T9C(efX([5;H8?5;(bAT?>6?9(98(H:A679C(LWQQ(6@(<9($VT5:=:9(<9(atN(
G $AH?8(,_s(dd(R(CAHV98(ef(CA=[(T9(f5=:(<9(T-!H85;9Ts(A775:8(<9(RSQQ(6@(<9($A(98(OQQ(0%ef(1?8(,(
G !H85;9Ts(_S(d( RH7(R([5?C(eC96A?;9(T9(6A8?;(A=(:>I9?T( ](f9=;(_Q(6?;=89C(AIA;8(85=89(AT?69;8A8?5;( LC?(
&CH5:9(u(RES(9;(T-AMC9;H9(<9([:AH8=:9CN(
(
FH"N1/#)&#%'&/$/(&) %(81'..1."5/D) 5') ("&'"() H"C%8/) O%C5) /P"&'N1/) "1)51#)&/##%'() '$$'8#+)Q) %1) $"'(,#/) ,"1&/D)
R/(&/.S)T::)U9-OD);)V"1#5),/)51'&/W)
Ordonnance'surveillance'traitement'
(
G vA?:9([A?:9(85=89C(T9C(C96A?;9C(79;<A;8(T9(R9:(65?C(7=?C(85=C(T9C(65?C(
G %5;5@:A669(CA;@=?;(
G .T`H>6?9X(KM!RH(C9=T969;8(TA(7:96?B:9(C96A?;9(7=?C(_(65?C(7T=C(8A:<(
G vA?:9(85=C(T9C(65?C(d('v"X($2/(
(
(
2.4.5. LA'SURVEILLANCE'
*-9[[?HAH?8>(<=(8:A?8969;8(9C8(C=?I?9(7A:(
G *A(HT?;?U=9(d(>8A8(@>;>:ATX(H>7VAT>9CX(75?<C(
G *A(M?5T5@?9(d($2/(
*9(C=?I?(<9(TA(85T>:A;H9(<9(TA(H5:8?H58V>:A7?9(:975C9(C=:(d(

h(
(
G *A(HT?;?U=9(d(w<B69X(&!X(C?@;9C(?;[9H8?9=DX(<5=T9=:C(5CC9=C9C(
G *A(M?5T5@?9(d(@T`H>6?9X(bAT?>6?9X(;A8:>6?9X(H:>A8?;?;9X(2D(7=T65;A?:9(A=(65?;<:9(<5=89E(
0;( M?TA;( 9C8( ]( :>AT?C9:X( ?;?8?AT969;8( 85=C( T9C( RS( f5=:C( 7=?C( <9( 7T=C( 9;( 7T=C( 9C7AH>X( 9;( [5;H8?5;( <9( TA(
85T>:A;H9(H5;;=9(98(<9(TA(75C5T5@?9(:><=?89(<9(H5:8?H5m<9CE(%T(9C8(?675:8A;8(AIA;8(HVAU=9(HVA;@969;8(<9(
<5C9(<9(H5:8?C5;9E(
2.4.6. DECROISSANCE'DU'TRAITEMENT'
*A(<>H:5?CCA;H9(9C8(IA:?AMT9(C9T5;(T9C(>H5T9C(98(?T(;-`A(7AC(<9(7:585H5T9(IAT?<>E((
+;(@>;>:ATX(=;9(H5:8?H58V>:A7?9(](QXS(](QXp(6@eb@(7A:(f5=:(9C8(6A?;89;=9(f=CU=-](;5:6AT?CA8?5;(<9C(C?@;9C(
M?5T5@?U=9C(98(HT?;?U=9C(L9;I?:5;(=;(65?CN(AI9H(=;9(<?6?;=8?5;(<BC(TA(<?C7A:?8?5;(<=(C`;<:569X(9;(<9=D(
8967C(d((
G =;9(<>H:5?CCA;H9(x(:A7?<9(y(<-9;I?:5;(RQ(g(85=C(T9C(RS(f5=:CX(f=CU=-](QXS(6@eb@(7A:(f5=:(
G =;9(<>H:5?CCA;H9(7T=C(x(T9;89(y(7:5@:9CC?I9C(<9C(<5C9C(75=:(A889?;<:9(TA(<5C9(6?;?6AT9(AH8?I9(
(
G SQ(6@(T9C(_(7:96?B:9C(C96A?;9C((
G ,?6?;=9:(<9(RQ(6@(85=89C(T9C(P(C96A?;9C(f=CU=-](PQ(6@((
G +;C=?89(<9(PXS(6@(85=89C(T9C(P(C96A?;9C(f=CU=-](RQ(6@(
G /=?C(_(C96A?;9C(](RQ(6@((
G ,?6?;=9:(<-R(6@(85=89C(T9C(_(C96A?;9C(
(
0;(A::i8(H567T98(<9C(H5:8?H5m<9C(9;(RP(](RO(65?C(CA=[(?;C=[[?CA;H9(C=::>;AT?9;;9(9C8(TA(:B@T9E(
*9(85=8(C5=C(H5=I9:8(<9(TA(C=:I9?TTA;H9(HT?;?U=9(98(<-=;9(69C=:9(<9(TA($2/(AIA;8(HVAU=9(65<?[?HA8?5;E((
+;(HAC(<9(:97:?C9(<=(C`;<:569(?;[TA66A85?:9(ACC5H?>(5=(;5;(](C?@;9C(>I5HA89=:C(<9(:97:?C9(<=(K5:85;X(
=;9(:>I?C?5;(<9(TA(<5C9(C9:A([A?89E(+;(HAC(<-A=@69;8A8?5;(<9(TA($2/(d(
G ,9(u(_Q(d(:9C89:(7AT?9:(79;<A;8(=;(65?C(98(:9;[5:H9:(C=:I9?TTA;H9(
G ,9(z(_Q(d(:9I9;?:(](TA(75C5T5@?9(A;8>:?9=:9X(6A:U=9:(=;(7AT?9:(7T=C(T5;@(](H9(;?I9A=(98(:97:9;<:9(TA(
<?6?;=8?5;(7T=C(7:5@:9CC?I969;8E(
2.4.7. LES'QUESTIONS'DE'LA'VIE'DE'TOUS'LES'JOURS…'
2.4.7.1. Un'antécédent'de'tuberculose,'Comment'le'prendre'en'compte'?''
/:>H?C9:(A;;>9(<9(TA(8=M9:H=T5C9(d(
G hO(](SR(d(/!"X(C8:97856`H?;9(
G 2?6?[5;(A77A:=(9;(SP((
G 2?[A67?H?;9(9;(WO(
"?(A;8>:?9=:(](R^hO(T9(7A8?9;8(79=8(;9(7AC(AI5?:(:9r=(<9(8:A?8969;8(A;8?(8=M9:H=T9=DX(?T([A=8(8:A?89:(_(65?C(
LYa(<5:6A;8CNX(C5?8(7A:(%'K(C9=TX(C5?8(9;(ACC5H?A8?5;(AI9H(:?[A67?H?;9(L2?[?;AVsN(
2.4.7.2. Une'cataracte'débutante'?'
*9C( H5:8?H5m<9C( 79=I9;8( A@@:AI9:( TA( HA8A:AH89( I5?:9( TA( H:>9:E( "?( 9C8( 9TT9( T?>9( A=D( H5:8?H5m<9CX( T9( <>TA?(
<-A77A:?8?5;( 9C8( <9( 7T=C( <9( R( A;E( +TT9( :>@:9CC9( 7A:8?9TT969;8( ]( T-A::i8( <=( 8:A?8969;8E( $979;<A;8X( C?(
?;<?HA8?5;(H5:8?H5m<9C(9C8([5:69TT9X(?T([A=8(75=:C=?I:9(T9(8:A?8969;8X(9;(CAHVA;8(U=9(TA(HV?:=:@?9(<969=:9(
75CC?MT9E(
2.4.7.3. Insomnies,'irritabilité':'est‐ce'la'maladie'?'
%T([A=8(:ACC=:9:(98(?;C?C89:(U=-=;9(A6>T?5:A8?5;(A77A:A?8:A(A7:BC(:><=H8?5;(<9C(<5C9CE(%T([A=8(?;C?C89:(C=:(TA(
65;5(7:?C9(T9(6A8?;(98X(C?(;>H9CCA?:9X(8:A;C?85?:969;8(7:575C9:(C56;?[B:9(<9(<=:>9(AH8?5;(H5=:89E(
%T([A=8(C9(6>[?9:(<9(8:5=MT9C(7C`HV?A8:?U=9C(75CC?MT9C(AI9H(<>H5679;CA8?5;(<9(7C`HV5C9E(
2.4.7.4. Le'risque'infectieux'
!7:BC(W(65?C(<9(C=?I?({(<5=T9=:(VA;HV9(:9;<A;8(6A:HV9(<?[[?H?T9E((
*9( 8AMT9A=( C=?IA;8( 65;8:9( T9C( 7:?;H?7AT9C( ?;[9H8?5;C( :A775:8>9C( <A;C( TA( T?88>:A8=:9( 6><?HAT9( HV9l( T9C(
7A8?9;8C(:9H9IA;8(=;9(H5:8?H58V>:A7?9(7:5T5;@>9(
(

S(
(
Infections'bactériennes'
%;[9H8?5;C(](7`5@B;9C(LC8A7V`T5H5U=9X(MAH?TT9C(.:A6(;>@A8?[N(
"AT65;9TT5C9(
*?C8>:?5C9(
'5HA:<?5C9(
&=M9:H=T5C9(
Infections'virales'
1A:?H9TT9(l5;A(
K9:7BC(
$`856>@AT5I?:=C(
K>7A8?89C(I?:AT9C(Y(98($(
Infections'fungiques'
/;9=65H`C85C9(
!C79:@?TT5C9(
$:`785H5HH5C9(
$A;<?<5C9(
Infections'parasitaires'
!;@=?TT=T5C9(
&5D57TAC65C9(
(
(
*9( 8AMT9A=( C=?IA;8( 7:>C9;89( T9C( 69C=:9C( I?CA;8( ]( 7:>I9;?:( T9C( H567T?HA8?5;C( ?;[9H8?9=C9C( <9( TA(
H5:8?H58V>:A7?9(C`C8>6?U=9(
(
Infection'
Contexte'favorisant'les'complications'
infectieuses'de'la'corticothérapie'
Bilan''
Prévention'
Tuberculose'
!;8>H><9;8(<9(8=M9:H=T5C9(
?;C=[[?CA669;8(8:A?8>9(
">U=9TT9C(:A<?5T5@?U=9C(<9(8=M9:H=T5C9(
#:?@?;A?:9(<|=;9(l5;9(<|9;<>6?9(
&AMA@?C69X(<?AMB89X(<>;=8:?8?5;X(
6ATA<?9(:9C7?:A85?:9(HV:5;?U=9(
$5:8?H58V>:A7?9(7:>I=9(](=;9(<5C9(<|A=(
65?;C(RS(6@ef(79;<A;8(A=(65?;C(=;(
65?C(
2D(<9(8V5:AD(
%,2(
}=A;8?v+2#'G&YG
.5T<(L;5;(
:96M5=:C>N(
&:A?8969;8(<|=;9(
?;[9H8?5;(8=M9:H=T9=C9(
TA89;89(
Varicelle'
!MC9;H9(<|A;8>H><9;8(<9(IA:?H9TT9(
$5:8?H58V>:A7?9(7:>I=9(A=D(<5C9C(<9(
7:><;?C5;9(C=?IA;89C(
+;[A;8C(d(~(P(6@eb@(7A:(f5=:(79;<A;8(
7T=C(<|=;9(C96A?;9(5=(~(R(6@eb@(7A:(
f5=:(79;<A;8(7T=C(<|=;(65?C(
(!<=T89C(d(~(hQ(6@ef(<=:A;8(7T=C(<|=;9(
C96A?;9X(T5:C(<9C(8:5?C(65?C(7:>H><9;8C(
">:5T5@?9(1•1(
(
Hépatite'B'
"=f98C(75:89=:C(HV:5;?U=9C(<=(1KY(L!@(
KY"(tN(
">:5T5@?9(KY1(
&:A?8969;8(A;8?I?:AT(d(
A;89HAI?:(7T=8j8(U=9(
TA6?I=<?;9(
Hépatite'C'
"=f98C(75:89=:C(HV:5;?U=9C(<=(1K$(
">:5T5@?9(K$1(
"=:I9?TTA;H9(<9C(
8:A;CA6?;AC9C(
Pneumocystose'
$,h(u(PQQe66_(
$5:8?H58V>:A7?9(7:>I=9(](=;9(<5C9(<|A=(
65?;C(RS(6@ef(79;<A;8(A=(65?;C(=;(
65?C(
'=6>:A8?5;(<9C(
*&$,h(
!;8?M?57:57V`TAD?9(7A:(
8:?6>8V57:?69(98(
C=T[A6>8V5DAl5T9(
Anguillulose'
">f5=:(9;(l5;9(<|9;<>6?9(
%;89::5@A85?:9(
$=:9(C`C8>6A8?U=9(
<|?I9:69H8?;9(5=(
<|ATM9;<Al5T9(
Grippe'
J(
J(
1AHH?;A8?5;(
Infection'
pneumocoque'
J(
J(
1AHH?;A8?5;(
'